Addus HomeCare (NASDAQ:ADUS) Posts Earnings Results

Addus HomeCare (NASDAQ:ADUS) announced its quarterly earnings results on Monday. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14, Briefing.com reports. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The business had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same period last year, the business earned $0.94 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis.

Addus HomeCare Stock Down 1.8 %

Addus HomeCare stock traded down $2.28 during trading on Wednesday, reaching $122.22. The stock had a trading volume of 152,278 shares, compared to its average volume of 136,893. The stock has a market cap of $2.21 billion, a PE ratio of 30.09, a P/E/G ratio of 2.35 and a beta of 1.01. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14. Addus HomeCare has a 52-week low of $78.35 and a 52-week high of $126.70. The business has a 50 day moving average price of $118.43 and a 200 day moving average price of $105.29.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ADUS shares. Bank of America raised their price objective on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Macquarie started coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective for the company. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday. TD Cowen raised their price objective on shares of Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. Finally, StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. One research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average target price of $120.71.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,186,500.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.